Toggle Dropdown
Groups
Announcements
Projects
Ideas
Welcome guest
Log in
Practice
My Requests
All Requests
Drill Partners
Digital games
Projects
Goals
Loading
Loading...
0
0
Vir Biotech Catapults On Its $1.71 Billion Deal With Astellas - Investor's Business Daily
2/24/26 at 1:09pm
Organization
Investor's Business Daily
29 words
0
Comments
Vir posted strong results for a prostate cancer treatment and crushed fourth-quarter views.
Pharmaceuticals & Biotech
Business & Industrial
Company News
Financial Markets News
You are the first to view
https://www.investors.com/news/technology/vir-stock-astellas-deal-prostate-cancer-treatment/
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...